ArticleMolecular cancer therapeutics2018

Dual Targeting of Aurora Kinases with AMG 900 Exhibits Potent Preclinical Activity Against Acute Myeloid Leukemia with Distinct Post-Mitotic Outcomes.

Marc Payton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.